|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
on1352969516 |
003 |
OCoLC |
005 |
20241006213017.0 |
006 |
m o d |
007 |
cr un|---aucuu |
008 |
221203s2022 sz o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d GW5XE
|d EBLCP
|d YDX
|d UKAHL
|d OCLCQ
|d OCLCF
|d CASUM
|d OCLCO
|d WSU
|d OCLCO
|d OCLCL
|d SFB
|d OCLCO
|
019 |
|
|
|a 1352417813
|a 1354208120
|
020 |
|
|
|a 9783031087745
|q (electronic bk.)
|
020 |
|
|
|a 3031087747
|q (electronic bk.)
|
020 |
|
|
|z 9783031087738
|
020 |
|
|
|z 3031087739
|
024 |
7 |
|
|a 10.1007/978-3-031-08774-5
|2 doi
|
035 |
|
|
|a (OCoLC)1352969516
|z (OCoLC)1352417813
|z (OCoLC)1354208120
|
050 |
|
4 |
|a RC349.D52
|
072 |
|
7 |
|a MMP
|2 bicssc
|
072 |
|
7 |
|a MED056000
|2 bisacsh
|
072 |
|
7 |
|a MKS
|2 thema
|
049 |
|
|
|a HCDD
|
245 |
0 |
0 |
|a Neuroimaging pharmacopoeia /
|c Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer, editors.
|
250 |
|
|
|a 2nd ed.
|
260 |
|
|
|a Cham :
|b Springer,
|c 2022.
|
300 |
|
|
|a 1 online resource (413 p.)
|
505 |
0 |
|
|a Intro -- Contents -- Part I: Drugs and Alcohol -- 1: Tobacco -- 1.1 Uses -- 1.2 Mechanism -- 1.3 Imaging Findings -- 1.3.1 Stroke -- 1.3.2 Cerebral Aneurysm -- 1.3.3 Cerebral Venous Thrombosis -- 1.3.4 Head and Neck Cancer, Squamous Cell Carcinoma -- 1.3.5 Brain Metastases -- 1.3.6 Warthin Tumor -- 1.3.7 Smoking-Induced Nasopharyngeal Lymphoid Hyperplasia -- Suggested Reading -- 2: Alcohol -- 2.1 Uses -- 2.2 Mechanism -- 2.3 Imaging Findings -- Suggested Reading -- 3: Methanol -- 3.1 Uses -- 3.2 Mechanism -- 3.3 Imaging Findings -- 3.4 Differential Diagnosis
|
505 |
8 |
|
|a Suggested Reading -- 4: Cannabis (Marijuana) -- 4.1 Uses -- 4.2 Mechanism -- 4.3 Imaging Findings -- 4.4 Differential Diagnosis -- Suggested Reading -- 5: Synthetic Cannabinoids -- 5.1 Uses -- 5.2 Mechanism -- 5.3 Imaging Findings -- 5.4 Differential Diagnosis -- Suggested Reading -- 6: Crack and Cocaine -- 6.1 Uses -- 6.2 Mechanism -- 6.3 Imaging Findings -- 6.4 Differential Diagnosis -- Suggested Reading -- 7: Amphetamines -- 7.1 Uses -- 7.2 Mechanism -- 7.3 Imaging Findings -- 7.4 Differential Diagnosis -- Suggested Reading -- 8: Opioids -- 8.1 Uses -- 8.2 Mechanism
|
505 |
8 |
|
|a 8.3 Imaging Findings -- 8.4 Differential Diagnosis -- Suggested Reading -- 9: Betel Nuts -- 9.1 Uses -- 9.2 Mechanism -- 9.3 Imaging Findings -- 9.4 Differential Diagnosis -- Suggested Reading -- 10: Licorice -- 10.1 Uses -- 10.2 Mechanism -- 10.3 Imaging Findings -- 10.4 Differential Diagnosis -- Suggested Reading -- 11: Centella asiatica -- 11.1 Uses -- 11.2 Mechanism -- 11.3 Imaging Findings -- 11.4 Differential Diagnosis -- Suggested Reading -- Part II: Contrast Agents -- 12: Iodinated Contrast Agents -- 12.1 Uses -- 12.2 Mechanism -- 12.3 Imaging Findings
|
505 |
8 |
|
|a 12.4 Differential Diagnosis -- Suggested Reading -- 13: Gadolinium-Based Contrast Agents -- 13.1 Uses -- 13.2 Mechanism -- 13.3 Imaging Findings -- 13.4 Differential Diagnosis -- Suggested Reading -- 14: Ferumoxytol -- 14.1 Uses -- 14.2 Mechanism of Action -- 14.3 Imaging Findings -- 14.4 Differential Diagnosis -- Suggested Reading -- 15: Pantopaque (Myodil, Iodophenylundecylic Acid) -- 15.1 Uses -- 15.2 Mechanism -- 15.3 Imaging Findings -- 15.4 Differential Diagnosis -- Suggested Reading -- 16: Thorium Dioxide (Thorotrast) -- 16.1 Uses -- 16.2 Mechanism -- 16.3 Imaging Findings
|
505 |
8 |
|
|a 16.4 Differential Diagnosis -- Suggested Reading -- Part III: Chemotherapy -- 17: Temozolamide (Temodar) -- 17.1 Uses -- 17.2 Mechanism -- 17.3 Imaging Findings -- 17.4 Differential Diagnosis -- Suggested Reading -- 18: 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU -- Carmustine) Polymer Wafer (Gliadel) -- 18.1 Uses -- 18.2 Mechanism -- 18.3 Imaging Findings -- 18.4 Differential Diagnosis -- Suggested Reading -- 19: Methotrexate -- 19.1 Uses -- 19.2 Mechanism -- 19.3 Imaging Findings -- 19.4 Differential Diagnosis -- Suggested Reading -- 20: 5-Fluorouracil -- 20.1 Uses
|
500 |
|
|
|a 20.2 Mechanism
|
520 |
|
|
|a This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The books closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. .
|
588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed December 16, 2022).
|
650 |
|
0 |
|a Nervous system
|x Imaging
|v Case studies.
|
650 |
|
0 |
|a Nervous system
|x Diseases
|x Diagnosis
|v Case studies.
|
650 |
|
0 |
|a Nervous system
|x Diseases
|x Treatment.
|
650 |
|
0 |
|a Pharmacopoeias.
|
650 |
|
0 |
|a Diagnosis, Differential.
|
650 |
|
0 |
|a Neurology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Toxicology.
|
650 |
|
0 |
|a Brain
|x Imaging.
|
650 |
|
7 |
|a pharmacology.
|2 aat
|
650 |
|
7 |
|a toxicology.
|2 aat
|
650 |
|
7 |
|a Diagnosis, Differential
|2 fast
|
650 |
|
7 |
|a Nervous system
|x Diseases
|x Diagnosis
|2 fast
|
650 |
|
7 |
|a Nervous system
|x Diseases
|x Treatment
|2 fast
|
650 |
|
7 |
|a Nervous system
|x Imaging
|2 fast
|
650 |
|
7 |
|a Pharmacopoeias
|2 fast
|
650 |
|
7 |
|a Malalties del sistema nerviós.
|2 thub
|
650 |
|
7 |
|a Diagnòstic per la imatge.
|2 thub
|
650 |
|
7 |
|a Farmacopees.
|2 thub
|
650 |
|
7 |
|a Diagnòstic diferencial.
|2 thub
|
655 |
|
0 |
|a Electronic books.
|
655 |
|
7 |
|a Case studies
|2 fast
|
655 |
|
7 |
|a Case studies.
|2 lcgft
|
655 |
|
7 |
|a Études de cas.
|2 rvmgf
|
655 |
|
7 |
|a Llibres electrònics.
|2 thub
|
700 |
1 |
|
|a Ginat, Daniel Thomas.
|1 https://id.oclc.org/worldcat/entity/E39PCjKkJHj4wwckQkH9tpHdXq
|
700 |
1 |
|
|a Small, Juan E.
|1 https://id.oclc.org/worldcat/entity/E39PCjFbWWbYQJfKHPRRMj68BX
|
700 |
1 |
|
|a Schaefer, Pamela W.
|1 https://id.oclc.org/worldcat/entity/E39PCjKYfBCVYC6DvpYK4Fm6Dm
|
758 |
|
|
|i has work:
|a Neuroimaging pharmacopoeia (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGwqtjmfbXPttfgR69wvjK
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Ginat, Daniel Thomas
|t Neuroimaging Pharmacopoeia
|d Cham : Springer International Publishing AG,c2023
|z 9783031087738
|
856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-3-031-08774-5
|y Click for online access
|
903 |
|
|
|a SPRING-MED2022
|
994 |
|
|
|a 92
|b HCD
|